SCHEMBL13601667

SCHEMBL13601667

CN(C)CCCOC(=O)CCC(=O)N1CCN(C)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 2/20 0.41
DNM1 Q05193 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
RAB9A P51151 3/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GNAI3 P08754 2/20 0.37
GNAO1 P09471 2/20 0.37
GNAI1 P63096 2/20 0.37
PDE3B Q13370 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601664 0.91 DNM1 (0.46) TSHRLMNAPOLBALDH1A1DNM1
SCHEMBL12881501 0.89 GNAI3 (0.51) TSHRLMNAPOLBALDH1A1DNM1
SCHEMBL12881521 0.89 BDKRB1 (0.42) TSHRLMNAPOLBALDH1A1DNM1
SCHEMBL12881529 0.88 BDKRB1 (0.41) TSHRLMNAPOLBALDH1A1RAB9A
SCHEMBL13601633 0.84 NPC1 (0.55) TSHRLMNAPOLBALDH1A1DNM1
SCHEMBL13601659 0.84 LMNA (0.49) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL4685619 0.82 ALDH1A1 (0.46) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL13601506 0.82 DNM1 (0.43) TSHRALDH1A1DNM1SMN1; SMN2RAB9A
SCHEMBL12259091 0.81 SIGMAR1 (0.48) ALDH1A1SMN1; SMN2KMT2AMEN1HPGD
SCHEMBL13601661 0.81 HTR2C (0.51) TSHRLMNAPOLBALDH1A1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed